By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Custom nucleic acids developer Integrated DNA Technologies said today that Glycon will distribute its product and service offerings in Australia.

Under the partnership, Glycon, situated in New South Wales, Australia, will distribute and provide technical support for IDT's portfolio of synthetic DNA and RNA oligos, genes, and supporting products. Glycon will provide local sales and customer support to complement IDTs telephone, e-mail, and web chat services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.